Search Posters

Search Poster Presentation 

Poster Number Poster Title Poster Type Date/Time Poster Presenter
M 01 Effect of Albumin on Stability of Silver Nanoparticles in Biological Media Student Mon, Jun 15 9:30AM Tea Crnkovic
M 02 A Systematic Review of Observational Studies Evaluating Cardiovascular Outcomes of Testosterone Therapy in Men Student Mon, Jun 15 9:30AM Anna Hung
M 03 Spontaneous Reports and Electronic Health Records for Safety Signal Detection Student Mon, Jun 15 9:30AM Alexandra Pacurariu
M 04 A Retrospective Study of Cutaneous Adverse Drug Reactions (CADRs) in Patients Coming to Tertiary Care Hospitals Student Mon, Jun 15 9:30AM Khyati Pramod Doshi
M 05 Evaluation of Safety Profiles of Drugs for Blood Cancer Approved in Japan Student Mon, Jun 15 9:30AM Sachie Kubota
M 06 Characteristics of Anti-Cancer Drug Studies Registered on the Chinese Clinical Trial Registry (ChiCTR) from 2007 to 2014 Student Mon, Jun 15 9:30AM Menghuan Song
M 07 An Assessment of the Double Medicine Dossier Submission as a Tool to Strengthen Health Regulatory System Student Mon, Jun 15 9:30AM Varley Dias Sousa
M 08 Regulatory Affairs Mobile Applications: Barriers, Benefits and Implications for Patients Student Mon, Jun 15 9:30AM Kamilah Rashid
M 09 Novel Strategy to Find Drugs for Autosomal Dominant Polycystic Disease Student Mon, Jun 15 9:30AM Parama Paul
M 10 The Signaling Effects of Stacked FDA Designations Student Mon, Jun 15 9:30AM Kathleen Miller
M 11 Role of Purinergic P2X4Rs in Regulating Dopamine Dependent Signaling Cascades within Basal Ganglia Circuitry Student Mon, Jun 15 9:30AM Sheraz Khoja
M 12 Impact of Global Warming on Malaria and Dengue in Africa: Prevention and Control through Regulation Student Mon, Jun 15 9:30AM Efstathia Sergi
M 13 A Cost-Benefit Framework for Modeling Large-Scale Implementation of Counterfeit Medicine Technologies Student Mon, Jun 15 9:30AM Catherine Y. Liang
M 14 Comparative Effectiveness of Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention Among Medicare Patients Student Mon, Jun 15 9:30AM Ruchitbhai Mukesh Shah
M 15 Projecting Enrollment Across Multiple Studies in a Clinical Trials Consortium: A Forecasting Tool Student Mon, Jun 15 9:30AM Jeromie Ballreich
M 16 Spontaneous Adverse Drug Reactions Reporting by Patients in Canada: A Multi-Method Study Student Mon, Jun 15 9:30AM Rania Dweik
M 17 Applying Survival Analysis to Predict Staff Attrition Student Mon, Jun 15 9:30AM Haojin Zhai
M 18 The P2X4 Receptor: A Potential Pharmaceutical Target for Cystic Fibrosis Patients Student Mon, Jun 15 9:30AM Kristin Elizabeth Thompson
M 19 Development and Validation of a Discrete Event Simulation Model to Evaluate the Use of Electronic Cigarettes in the US Student Mon, Jun 15 9:30AM Kunal Saxena
M 20 Assisted Diagnosis of Anxiety Disorders with Standard Questionnaires in Primary Care: A Spanish Cost Evaluation Student Mon, Jun 15 9:30AM Elena Olariu
T 01 Assessing the Current Landscape of Pharmaceutical Industry Post-Doctoral Fellowships Professional Tue, Jun 16 9:00AM Brittny Ann Rule
T 02 Patient Knowledge of Safe Use of ER/LA Opioid Analgesics Following Implementation of the Class-Wide REMS Professional Tue, Jun 16 9:00AM Stephan Lanes
T 03 Biosafety Gene Therapy: Navigating the Regulatory Maze Professional Tue, Jun 16 9:00AM Chris Jenkins
T 04 Clinical Relevance and Utility of Boxed Warnings in US Prescribing Information Professional Tue, Jun 16 9:00AM Christine M. Cheng
T 05 Advancing Medical Information Services To Impact Patient Care: Collection Of Insights From Healthcare Practitioners Professional Tue, Jun 16 9:00AM Roshni Patel-Romero
T 06 Impact of the Nonclinical Juvenile Animal Studies on Pediatric Medicines Information Professional Tue, Jun 16 9:00AM Dinah Duarte
T 07 Steps on a Journey: Re-Use of Analysis Scripts and Standardized Tuberculosis Trial Data Professional Tue, Jun 16 9:00AM Xin (Joy) Li
T 08 Can Social Listening be Used to Augment Existing Data Sources for Monitoring the Safety of Consumer Health Care Products? Professional Tue, Jun 16 9:00AM James Blowers
T 09 Regulatory Gaps - Industry's Perspectives on Asia's Regulatory Authorities Professional Tue, Jun 16 9:00AM James Leong
T 10 Pharmacovigilance Industry Benchmarking on Global Methodologies for Collecting and Processing Off-Label Use Reports Professional Tue, Jun 16 9:00AM Amanda Bowles
T 11 The Case for Electronic Data Capture of Abdominal Pain in Crohn’s Disease: A Comparison of Diary Methods Professional Tue, Jun 16 9:00AM Leighann Litcher-Kelly
T 12 Feasibility of Replacing the Thorough QT (TQT) Study with Intense ECG Data Collection in Early Clinical Studies Professional Tue, Jun 16 9:00AM Nancy Wang
T 13 Assessing Bias in Administrative Database Studies of Vaccine Completion Due to Excluding Subjects with Incomplete Follow-up Professional Tue, Jun 16 9:00AM Scott Charles Quinlan
T 14 Design and Development of an eCOA Specific Solution for Capturing Patient Data in Diabetes Clinical Trials Professional Tue, Jun 16 9:00AM Paul O'Donohoe
T 15 Engage Patients with Innovative Global Digital Patient Platform Professional Tue, Jun 16 9:00AM Helen Lee
T 17 Utilizing Regional and National Student Recruitment Events to Maximize Awareness of Post-PharmD Opportunities in Industry Professional Tue, Jun 16 9:00AM Amy Monpara
T 18 The Impact of the Establishment of Integrated Medicinal Product Review Office (IMPRO) in Taiwan Professional Tue, Jun 16 9:00AM Yan-Fang Chen
T 19 Drug Lag and Approval Time Metrics - Are They Good Markers to Assess the Global Regulatory Environment? Professional Tue, Jun 16 9:00AM Magdalena Bujar
T 20 Analyzing Global Recruitment Strategies to Improve Local Trial Enrollment - A Global Investigation Into “What Works Where” for Patient Recruitment and Retention Tools and Techniques Professional Tue, Jun 16 9:00AM Chris Frega
T 21 Improving Hepatic-Impairment Patient Recruitement with a University Hospital Center-CRO Partnership: A Benchmarking Analysis Professional Tue, Jun 16 9:00AM Rachida Essalihi
T 22 Monitoring Interactive Response Technology Vendor Implemented Randomization and Dosing Systems Professional Tue, Jun 16 9:00AM Jason McCoy
T 23 Evolution of a Unique Blend of Business Process and Technology to Enhance Medical Affairs Capabilities Professional Tue, Jun 16 9:00AM Manish Dave
T 24 Implementing CDISC Standards in an Early Phase CRO: Successes and Challenges Professional Tue, Jun 16 9:00AM Pascal Guibord
T 25 A Pitfall in the Clinical Study Enrollment of Postmenopausal Females Professional Tue, Jun 16 9:00AM Eunhee Chung
T 26 Survey of IRB Review of Urgent Patient Specific Protocols Professional Tue, Jun 16 9:00AM Bambi Grilley
T 27 Lack of Inter-Ethnic Difference in QT-Susceptibility to Moxifloxacin: Two Independent TQT Studies in Caucasian and Asian Populations Professional Tue, Jun 16 9:00AM Yaning Wang
T 28 Implementing Quality Risk Management and Risk-Based Monitoring: Practical Guidelines from Sponsors and Sites Professional Tue, Jun 16 9:00AM Amita Malik
T 29 Measurement Equivalence of the SF-36v2 on a Handheld Device and Smartphone App Professional Tue, Jun 16 9:00AM Susan M. Dallabrida
T 30 How to Maximize Data Quality in Retrospective Chart Review Studies Professional Tue, Jun 16 9:00AM Dara Stein
T 31 Benefit-Risk Assessments (BRAs) of an Established Products’ Portfolio Professional Tue, Jun 16 9:00AM Rosa A. Piccirillo
T 33 Results of An Online Survey of Stakeholders Regarding Barriers and Solutions to Clinical Trial Recruitment Professional Tue, Jun 16 9:00AM Elizabeth Mahon
T 34 Process for Ensuring Clinical Trial Product Quality Professional Tue, Jun 16 9:00AM Janie B. Russell
T 35 Attractiveness of PRO Mixed Modes – What are Patients Saying? Professional Tue, Jun 16 9:00AM Jennifer Ross
T 36 Efficient and Innovative Clinical Trial Enrollment Using Online and Social Media Professional Tue, Jun 16 9:00AM Mark Joing
T 37 The Cost Effective Benefits of Behavioral Psychology on Improving Data Quality Professional Tue, Jun 16 9:00AM Shawn Levin
T 38 An Approach to Aggregate Safety Reporting of Drug and Device Constituent Parts of Combination Products Professional Tue, Jun 16 9:00AM Xaymara Roman
T 39 Analyzing the Relative Recruitment Performance between Highly-Utilized and Low-Utilized Sites in 5 TAs in 4 Asian Countries Professional Tue, Jun 16 9:00AM HyunJoo Rhee
T 40 How IDMP Can Help Structure Product Information / Labeling Professional Tue, Jun 16 9:00AM Romuald Braun
T 41 Simultaneous Marketing Authorization Applications: Pharma Urban Legend or Reality? Professional Tue, Jun 16 9:00AM Stacie O'Sullivan
T 42 Results Reporting to ClinicalTrials.gov and EudraCT - A Consolidated Approach and First-hand Experiences Professional Tue, Jun 16 9:00AM Mathias Poensgen
W 01 Expanding Knowledge of Pharmaceutical Industry Careers to PharmD Students: Impact of National Webinars Professional Wed, Jun 17 9:00AM Corey Robinson
W 02 EHR for Identifying and Recruiting Patients in Clinical Trials: Feasibility Study of Myocardial Infarction Using the CPRD Professional Wed, Jun 17 9:00AM Antonis A. Kousoulis
W 03 Information Architecture for Publishing Stem Cell Data in Open Source Platform Professional Wed, Jun 17 9:00AM Bhanu Bahl
W 04 Review of Adherence Measures for Use in Phase IV Studies and Recommendations for a New Standardized Generic Measure Professional Wed, Jun 17 9:00AM Colleen A. McHorney
W 05 Monoclonal Antibodies and Juvenile Animal Studies as a Model for Testing Toxicity in Children Professional Wed, Jun 17 9:00AM Dinah Duarte
W 06 Social Listening for Pharmacovigilance: How Does the Content and Level of Detail in Social Media Compare to Spontaneous Reports Professional Wed, Jun 17 9:00AM Heidi G. Bell
W 07 Enhancing Pharmacokinetic Studies to Support Tier 2 Labeling Claims for Abuse Deterrent Opioids Professional Wed, Jun 17 9:00AM Hiren Mehta
W 08 Ex-US Sites in A Multinational Study: Should They Be Included Under a US IND or Not? Professional Wed, Jun 17 9:00AM Jacqueline M. Kline
W 09 Using Portfolio Analysis to Maximize Innovation and Optimize R&D Strategic Planning Professional Wed, Jun 17 9:00AM Jean Yuan
W 10 Transdermal Drug Innovation from 2000 to 2014: Current Status and Future Outlook Professional Wed, Jun 17 9:00AM Jessica Ruth Walter
W 11 Establishing Normal Ranges for ECG Intervals in a Normal Healthy Population Professional Wed, Jun 17 9:00AM Joy Olbertz
W 12 Failure Mode and Effects Analysis (FMEA): A Systematic and Defensible Approach to Risk Mitigation For A New Drug Regimen Professional Wed, Jun 17 9:00AM Anthony Gbadebo Oladipo
W 14 Compliant Presentation of Important Safety Information In A More Educational Format In Promotional Educational Programs Professional Wed, Jun 17 9:00AM Michael Varlotta
W 15 Strategic Considerations for Developing an Initial Pediatric Study Plan for a Proposed Biosimilar Professional Wed, Jun 17 9:00AM Sally Choe
W 16 A Determination of the Relative Risk of Hepatotoxicity Among Anti-Epileptic Drugs in the FDA Adverse Event Reporting System Professional Wed, Jun 17 9:00AM Roshawn Watson
W 17 Pharmacovigilance Process Innovation: Approach to Pharmacovigilance (PV) Process Enhancements in a Large Global Biotechnology Company Professional Wed, Jun 17 9:00AM Sadiqa Hafeez Mian
W 18 Incidence of Outcomes Relevant to Vaccine Safety Monitoring in a Large Commercially Insured Population Professional Wed, Jun 17 9:00AM Daina B. Esposito
W 19 Global Utilization of Breast Cancer Treatment Guidelines: A Survey of International Physician Practices Professional Wed, Jun 17 9:00AM Sukhleen (Sheena) Gurai
W 20 Precision Medicine Basket Trial Eligibility Across Race/Ethnicity: Implications for Ethnobridging and Clinical Application Professional Wed, Jun 17 9:00AM Todd Knepper
W 21 PMDA’s Relief Services for Drugs’ Adverse Health Effects Professional Wed, Jun 17 9:00AM Toshiyoshi Tominaga
W 22 Propensity Score Weighting and Stratification When the Relationship Between Treatment and Propensity Scores is Non-linear Professional Wed, Jun 17 9:00AM William G. Hawkes
W 23 Recent FDA GLP (Good Laboratory Practice) Inspections Conducted in China Professional Wed, Jun 17 9:00AM Zhou Chen
W 24 Current Drug Master File Status in Taiwan Professional Wed, Jun 17 9:00AM Shun-Lan Hsieh
W 25 Ignoring Global Feasibility and Site Networks for Your Rare Disease Study? You May Want to Re-consider Professional Wed, Jun 17 9:00AM Earl Seltzer
W 26 Exploring Phenome-wide Association Study (PheWAS) as an Option to Address Key Challenges of Pharmaceutical Industry Professional Wed, Jun 17 9:00AM Priyank Chopra
W 27 Japan PMDA Inspections from a CDM/EDC Perspective Professional Wed, Jun 17 9:00AM Ryan Michael Lariviere
W 28 Application of Structural Equation Modeling (SEM) in Asthma to Evaluate Small Airways Disease Professional Wed, Jun 17 9:00AM Thomas Zwingers
W 29 Factoring in Ethnicity, Gender, and Age in Specific Clinical Studies Professional Wed, Jun 17 9:00AM Andrew Melli
W 30 Clinical Monitoring Liaison, a New Oversight Role as a Practical Approach to Sponsor Involvement in Outsourced Trials Professional Wed, Jun 17 9:00AM Annelies Legters
W 31 Adaptive Clinical Trial Design in Head-to-Head Comparison of Two DPP-4 Inhibitors Professional Wed, Jun 17 9:00AM Natalia Vostokova
W 32 New Approaches to Assessing Medical Publication Impact in Social Media: Altmetric, PlumAnalytics, and Augmented Reality Professional Wed, Jun 17 9:00AM Catherine Skobe
W 33 Lessons Learned for Meeting Safety Reporting Requirements in Retrospective Chart Review Studies Professional Wed, Jun 17 9:00AM Catherine Sigler
W 34 From Concept to Reality: Developing an Operational Study Planning and Forecasting System Professional Wed, Jun 17 9:00AM DeAnn S. Hyder
W 35 Risk of Acute Renal Failure with Vildagliptin/Metformin Combination Use in Patients with Type 2 Diabetes Professional Wed, Jun 17 9:00AM Hong-Ah Kim
W 36 Development of an Electronic Diary with Spirometer Integration to Capture Patient Data in Asthma Clinical Trials Professional Wed, Jun 17 9:00AM Nora Ibrahimova
W 37 Use R for ESUB Module 5 Professional Wed, Jun 17 9:00AM Jingyuan Chen
W 38 eRecruitment - Multi-country, Multi-language Direct to Patient for Clinical Trials Professional Wed, Jun 17 9:00AM Lani Hashimoto
W 39 Recruitment and Screening for a Multi-Site Sleep Clinical Trial: Rolling Wave Planning Leading to Study Success Professional Wed, Jun 17 9:00AM Marianne Rufiange
W 40 Exploration of Protocol Complexity Factors and Impact on Protocol Variance Rates in a Subset of Clinical Trials Professional Wed, Jun 17 9:00AM Paige Ellison
W 41 Fifteen Years of Controlled Production and Consistency of Quality Attributes for a Glycosylated Monoclonal Antibody Therapy Professional Wed, Jun 17 9:00AM Amy Varga
W 42 Fibromyalgia Clinical Trial Analysis from 2004 to 2014 Professional Wed, Jun 17 9:00AM Elan Lutinger
W 43 Overview of the Health Canada Updated Clinical Trial Application Regulations on Review Process and Timelines Professional Wed, Jun 17 9:00AM Julie Massicotte